KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Dividends Paid - Common: 2017-2018

Historic Dividends Paid - Common for Amneal Pharmaceuticals (AMRX) over the last 1 years, with Dec 2018 value amounting to $2,000.

  • Amneal Pharmaceuticals' Dividends Paid - Common fell 99.99% to $2,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $203.0 million, marking a year-over-year change of. This contributed to the annual value of $183.0 million for FY2018, which is 51.23% down from last year.
  • According to the latest figures from Q4 2018, Amneal Pharmaceuticals' Dividends Paid - Common is $2,000, which was down 100.00% from $153.0 million recorded in Q2 2018.
  • In the past 5 years, Amneal Pharmaceuticals' Dividends Paid - Common ranged from a high of $153.0 million in Q2 2018 and a low of $2,000 during Q4 2018.
  • In the last 2 years, Amneal Pharmaceuticals' Dividends Paid - Common had a median value of $30.0 million in 2018 and averaged $52.6 million.
  • Data for Amneal Pharmaceuticals' Dividends Paid - Common shows a maximum YoY plummeted of 99.99% (in 2018) over the last 5 years.
  • Over the past 2 years, Amneal Pharmaceuticals' Dividends Paid - Common (Quarterly) stood at $20.0 million in 2017, then crashed by 99.99% to $2,000 in 2018.
  • Its last three reported values are $2,000 in Q4 2018, $153.0 million for Q2 2018, and $30.0 million during Q1 2018.